Hematologist
CION Cancer Clinics
Chimerism testing: whose marrow is it now? | CION Cancer Clinics
A chimerism test measures how much of your blood or marrow comes from your donor and how much is still your own. Full donor chimerism is what most teams hope for after a donor transplant. A mixed result is not automatically bad news, but a donor share that keeps falling can be an early warning. Here is how the test works, how to read the result, and what your team may do. At CION Cancer Clinics, our haematology team assesses whether a transplant or CAR-T fits your situation and coordinates care with qualified centres.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
The short answer
What does a chimerism test after a transplant mean?
A chimerism test shows how much of your blood or marrow now comes from your donor and how much is still your own. It is done only after a donor (allogeneic) transplant, and it tells the team whether the donor cells have taken over as planned.
Where the name comes from
After a donor transplant, your body carries cells with two different sets of genes: yours and your donor's. Doctors call a body like that a chimera, after a creature in old stories made of two animals. The test simply measures the mix.
Why the mix matters
The donor's immune cells are part of how a transplant keeps a blood cancer in check. If donor cells make up nearly all of your blood, the new immune system is in place. If your own cells are coming back, it can be an early hint that the graft is weakening or that the original disease is returning. It can also mean nothing worrying at all, which is why one result is never read alone.
When you are likely to have it
Most centres check chimerism at set points in the first year, often including the review around day 100, and again whenever the counts or another test raise a question. You do not need to ask for it; it is usually part of the routine follow-up plan your transplant centre gives you.
If your transplant used your own stem cells (an autologous transplant), there is no donor, so there is nothing for this test to measure.How the test works
How is a chimerism test done?
Samples before the transplant
A sample of your blood and one from your donor are stored before the transplant. They give the lab a genetic fingerprint for each of you.
A blood or marrow sample now
Usually an ordinary blood test. Sometimes it is run on a bone marrow sample taken for other reasons at the same time, so no extra needle is needed.
The lab compares markers
Small stretches of DNA that differ between you and your donor are counted. The lab works out what share of the cells carry the donor's pattern.
Sometimes cell by cell type
The lab may test T cells (immune cells) and other white cells separately. The two can tell different stories, and your team wants both.
Not sure whether this applies to you?
Ask an oncologistReading the report
What do the different results mean?
Labs describe the result as a share of donor cells. Each lab sets its own cut-offs, so read the words, not only the figure.
Full donor chimerism
All or almost all of the cells tested came from the donor. This is what most transplant teams hope to see, especially for leukaemia and other blood cancers.
Mixed chimerism, stable
Both your cells and the donor's are present, in a mix that is not changing much between tests. In some conditions, such as some non-cancer blood disorders, this can be acceptable.
Mixed chimerism, donor share falling
Your own cells are increasing test after test. This is the pattern that most often leads the team to act, because it can come before a relapse or graft failure.
Often followed by
- A repeat test sooner than planned
- A marrow test or disease-specific test
Different in T cells
The immune cells may be mixed while other cells are fully donor, or the reverse. Your haematologist reads the two together.
After the result
What might the team do if the result is mixed?
Often the first step is simply to repeat the test. A single mixed result, especially early after a transplant, can settle by itself. What matters most is the direction over several tests.
Adjusting immune-suppressing medicines
Medicines that stop graft-versus-host disease (GVHD) also hold back the donor's immune cells. If donor cells are falling, a team may plan a slow reduction of these medicines to let the donor cells push back. This carries a risk of GVHD, so it is done carefully and only by the team. Never change these medicines yourself because of a chimerism result.
A top-up from the donor
In some cases the team may discuss a donor lymphocyte infusion, which means giving extra immune cells collected from the same donor. It is not suitable for everyone. It can trigger GVHD, and it depends on the donor being available again.
Looking at the disease directly
Because chimerism is an indirect signal, the team may also check the marrow or run a test for the original disease before deciding anything.
What this page cannot tell you
This page cannot tell you what your own result means. The same figure is read differently for leukaemia than for thalassaemia, early after a transplant than a year later, and in T cells than in other white cells. Your transplant team knows your earlier results and the trend. Ask them what they expected to see, and what would change the plan.
Commonly believed
What do families often misread in a chimerism report?
"Mixed chimerism means the cancer is back."
Not on its own. Mixed results can come from healthy recipient cells that survived the treatment. The test cannot tell healthy cells from cancer cells, so the team uses other tests to answer that question.
"Full donor chimerism means it can never come back."
It is a good sign, and follow-up still continues. Relapse can occasionally happen even with fully donor blood, which is why disease checks carry on alongside it.
"My blood group changed, so something went wrong."
If the donor had a different blood group, your blood group often slowly changes to theirs. That is expected and is a sign the donor marrow is working. Tell any hospital about it before a transfusion.
"Now I carry my donor's DNA, so my children will too."
The change is in your blood-forming cells, not in eggs or sperm. It does not pass to children.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
What do the other words on the report mean?
- STR analysis
- The usual lab method. It compares short repeating stretches of DNA that differ between you and your donor.
- Peripheral blood
- An ordinary blood sample from a vein, as opposed to a marrow sample.
- CD3 or T-cell fraction
- The result for immune T cells only, tested separately.
- CD33 or myeloid fraction
- The result for another group of white cells, often closer to where myeloid leukaemias arise.
- Recipient
- You, the person who received the transplant.
Questions we are asked
Common questions about chimerism testing
How often is the chimerism test done?
It varies by centre and disease. Many teams test at set points in the first year, often including the day 100 review, and more often if a result is mixed. Some check less often once results have been fully donor for a long time. Your transplant team sets the schedule.
Does it need a bone marrow test?
Usually not. Most chimerism tests use an ordinary blood sample. A marrow sample may be tested too when a bone marrow test is already being done for another reason, because the two can give slightly different information.
Can any lab near home do this test?
Not usually. The lab needs the stored samples from before the transplant for you and your donor, so the test is normally run by, or through, the transplant centre's lab. Ask your centre how to send a sample if you live far away.
My result went from full donor to slightly mixed. Should I worry?
It deserves attention, not panic. Small changes can reflect test variation. The team will usually repeat the test and may check the disease directly. Ask when the repeat is due and what change would make them act. Do not alter any medicine while you wait.
Does chimerism matter after a transplant for thalassaemia or another non-cancer condition?
Yes, but it is read differently. In some non-cancer conditions a stable mix of donor and own cells can be enough to keep the blood healthy. What worries teams most is a steady fall in donor cells, which may point towards the graft failing.
Can the test tell us if the cancer has returned?
No. It counts whose cells are present, not whether any of them are cancer cells. It can raise a question that other tests then answer, such as a marrow examination or a test for measurable residual disease.
Is the test painful?
When it is done on blood, it feels like any other blood test. If a marrow sample is needed, the team uses local numbing medicine and sometimes sedation. Ask what pain relief is planned before the day so you can prepare.
Who can explain my report if I am back home?
Your transplant centre first, because it holds the earlier results. If you want help understanding the report in plain language, CION's haematology team can go through it with you and suggest the right questions to ask your transplant doctor.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- National Cancer Institute — NCI Dictionary of Cancer Terms
- National Cancer Institute — Stem Cell Transplants in Cancer Treatment
- Leukemia & Lymphoma Society — Stem Cell Transplantation
- American Cancer Society — Stem Cell or Bone Marrow Transplant
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Confused by a chimerism report?
Share it with us. CION's haematology team will explain it in plain language and help you prepare questions for your transplant centre. One helpline serves every CION centre.